Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Case Report

Vol. 3 No. 2 (1997)

Sequential use of Antibiotics and Adjuvant Chemotherapy Leading to a Fatal Pseudomembranous Colitis

  • Mark Basik
  • Barbara Roback
  • Marc Trudeau
DOI
https://doi.org/10.26443/mjm.v3i2.421
Submitted
October 29, 2020
Published
2020-12-01

Abstract

N/A

References

  1. Finny JMT. Gastroenterology for cicatrizing ulcer of the pyloris. Bulletin of Johns Hopkins Hospital 4: 53-55; 1893.
  2. Isselbacher KJ, et al. eds. Harrison’s principles of internal medicine. 13th edition. New York: McGraw Hill Inc.; 1995.
  3. Tedesco FJ. Pseudomembranous colitis: pathogenesis and therapy. Medical Clinics of North America 66(3): 655-664; 1982.
  4. Silva J. Update on pseudomembranous colitis. The Western Journal of Medicine 151(6): 644-648; 1989.
  5. Roda PI. Clostridium difficile colitis induced by cytarabine. American Journal of Clinical Oncology 10(5): 451-542; 1987.
  6. Miller SD, Koornhof HJ. Clostridium difficile colitis associated with the use of antineoplastic agents. European Journal of Clinical Microbiology 3(1): 10-13; 1984.
  7. Cudmore MA, Silva J, Fekety R, et al. Clostridium difficile colitis associated with cancer chemotherapy. Archives of Internal Medicine 142(2): 333-335; 1982.
  8. Silva J, Batts DH, Fekety R, et al. Treatment of clostridium difficile colitis and diarrhea with vancomycin. The American Journal of Medicine 71(5): 815-822; 1981.
  9. Volanovich V, LaPorta AJ, Garrett Wl, et al. Pseudomembranous colitis leading to toxic megacolon associated with antineoplastic chemotherapy. Diseases of the Colon and Rectum 35: 369-372; 1992.
  10. Fainstein V, Bodey GP, Fekety R. Relapsing pseudomembranous colitis associated with cancer chemotherapy. The Journal of Infectious Diseases 143(6): 865; 1981.
  11. Ivenson TJ, Chan A. Pseudomembranous colitis complicating chemotherapy. Lancet 339: 192-193; 1992.
  12. Satin AJ, Harrison CR, Hancock K et al. Relapsing clostridium difficile toxin-associated colitis in ovarian cancer patients treated with chemotherapy. Obstetrics and Gynecology 74(3 Pt 2): 487- 489; 1989.
  13. Milligan DW, Kelley JK. Pseudomembranous colitis in a leukemia unit: a report of five fatal cases. Journal of Clinical Pathology 32(12): 1237-1243; 1979.
  14. Early breast cancer trialists’ collaborative group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339: 1-15, 71-85; 1992.
  15. NIH consensus conference: adjuvant therapy for patients with colon and rectal cancer. JAMA 264: 1444-1450; 1990.
  16. Manabe Y, Vinetz J, Moore R, et al. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Annals of Internal Medicine 123(11): 835-840; 1995.
  17. Nardone D. Diagnosis of clostridium difficile colitis. Annals of Internal Medicine 125(6): 515-516; 1996.
  18. Vohra R, Prescott RJ, Banerje SS et al. Management of neutropenic colitis. Surgical Oncology 1(1): 11-15; 1992.
  19. Dosik GM, Luna M, Valdivieso M et al. Necrotizing colitis in patients with cancer. The American Journal of Medicine 67(4): 646-656; 1979.
  20. DeGara CJ, Gagie N, Arnold A, et al. Toxic megacolon associated with anticancer therapy. Canadian Journal of Surgery 34: 339-341; 1991.
  21. Atherton LD, Leib ES, Kay MD. Toxic megacolon associated with methotrexate therapy. Gastroenterology. 86(6): 1583-1588; 1984.
  22. Brooks RJ, Jones SE, Salmon SE, et al. Improved outcomes with early treatment in an adjuvant breast cancer program. Proc ASCO 2: 110; 1983.
  23. Pronzato P, Campora E, Amoroso D, et al. Impact of administration related factors on outcome of adjuvant chemotherapy for primary breast cancer. American Journal of Clincal Oncology 12(6): 481-485; 1989.
  24. Sertoli MR, Prozanto P, Rubagotti A, et al. A randomized study of perioperative chemotherapy in primary breast cancer. In: Salmon S, ed. Adjuvant Therapy of Cancer VI. W.B. Saunders Company; 1990: 196-203.
  25. Fisher B, Redmond C, Dimitrov NV, et al. A randomized clinical trial evaluating sequential methotrexate and flurouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. New England Journal of Medicine 320(8): 473-478; 1989.
  26. Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxic for heriorrhaphy and breast surgery. New England Journal of Medicine 322(3): 152-160; 1990.

Downloads

Download data is not yet available.